Randomized trial comparing three differe
โ
Liliana Chemello; Paola Bonetti; Luisa Cavalletto; Fabiola Talato; Valter Donado
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 769 KB
Alpha-interferon (IF"+) is an effective treatment for chronic hepatitis C, but only 20% to 30ยฐC of patients are apparently cured with the currently recommended schedule of 3 MU given three times a week for 6 months. To evaluate the efficacy of more aggressive treatment regimens, we have conducted a